Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses

Nature Nanotechnology

Volumn 8, Issue 2, 2013, Pages 130-136

  Yolamanova, Maral ^a   Meier, Christoph ^b   Shaytan, Alexey K ^b,c   Vas, Virag ^a   Bertoncini, Carlos W ^d   Arnold, Franziska ^a   Zirafi, Onofrio ^a   Usmani, Shariq M ^a   Müller, Janis A ^a   Sauter, Daniel ^a   Goffinet, Christine ^a   Palesch, David ^a   Walther, Paul ^b   Roan, Nadia R ^e   Geiger, Hartmut ^a   Lunov, Oleg ^b   Simmet, Thomas ^b   Bohne, Jens ^f   Schrezenmeier, Hubert ^g   Schwarz, Klaus ^g   Ständker, Ludger ^f   Forssmann, Wolf Georg ^f   Salvatella, Xavier ^d   Khalatur, Pavel G ^b,h   Khokhlov, Alexei R ^b,c   Knowles, Tuomas P J ⁱ   Weil, Tanja ^b   Kirchhoff, Frank ^a   Münch, Jan ^a   more..

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^e GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g German Red Cross Blood Donation Service Baden Wuerttemberg Hessen   (Germany)

^h A N NESMEYANOV INSTITUTE OF ORGANOELEMENT COMPOUNDS   (Russian Federation)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGES; BODY FLUIDS; CLINICAL RESEARCH; GENE TRANSFER; NANOFIBERS; PEPTIDES;

AMYLOID FIBRIL; CLINICAL APPLICATION; FORMATION KINETICS; PEPTIDE SYNTHESIS; RETROVIRAL GENE TRANSFERS; RETROVIRAL TRANSDUCTION; RETROVIRAL VECTORS; SELF-ASSEMBLE;

GENES;

AMYLOID; ENHANCING FACTOR C; NANOFIBER; NANOMATERIAL; PEPTIDE DERIVATIVE; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; MEDICAL RESEARCH; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; RISK ASSESSMENT; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS ATTACHMENT;

EID: 84873570411     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2012.248     Document Type: Article

References (30)

1. Mátrai, J., Chuah, M. K. & VandenDriessche, T. Recent advances in lentiviral vector development and applications. Mol. Ther. 18, 477-490 (2010).
2. Münch, J. et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131, 1059-1071 (2007).
3. Roan, N. R. et al. The cationic properties of SEVI underlie its ability to markedly enhance HIV infection. J. Virol. 83, 73-80 (2009).
4. Kim, K. et al. Semen-mediated enhancement of HIV infection is donordependent and correlates with the levels of SEVI. Retrovirology 7, 55 (2010).
5. Wurm, M. et al. The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J. Gene Med. 12, 137-146 (2010).
6. Wurm, M. et al. Improved lentiviral gene transfer into human embryonic stem cells grown in co-culture with murine feeder and stroma cells. Biol. Chem. 392, 887-895 (2011).
7. Roan, N. R. et al. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe 15, 541-550 (2011).
8. Arnold, F. et al. Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. J. Virol. 86, 1244-1249 (2012).
9. Kwong, P. D. et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659 (1998).
10. Knowles, T. P. & Buehler, M. J. Nanomechanics of functional and pathological amyloid materials. Nature Nanotech. 6, 469-479 (2011).
11. Dalhaimer, P., Bates, F. S. & Discher, D. E. Single molecule visualization of stable, stiffness-tunable, flow-conforming worm micelles. Macromolecules 36, 6873-6877 (2003).
12. Cerf, E. et al. Antiparallel b-sheet: a signature structure of the oligomeric amyloid b-peptide. Biochem. J. 421, 415-423 (2009).
13. Makin, O. S. & Serpell, L. C. Structures for amyloid fibrils. FEBS J. 272, 5950-5961 (2005).
14. Shaytan, A. K. et al. Self-assembling nanofibers from thiophene-peptide diblock oligomers: a combined experimental and computer simulations study. ACS Nano 5, 6894-6909 (2011).
15. Tiscornia, G., Singer, O. & Verma, I. M. Production and purification of lentiviral vectors. Nature Protoc. 1, 241-245 (2006).
16. Sandrin, V. et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes an CD34\+ cells derived from human and nonhuman primates. Blood 100, 823-832 (2002).
17. Schambach, A. et al. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol. Ther. 13, 391-400 (2006).
18. Schambach, A. et al. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther. 13, 1524-1533 (2006).
19. Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471 (1998).
20. Koeffler, H. P. & Golde, D. W. Human myeloid leukemia cell lines: a review. Blood 56, 344-350 (1980).
21. Leyva, F. J., Anzinger, J. J., McCoy, J. P. & Kruth, H. S. Evaluation of transduction efficiency in macrophage colony-stimulating factor differentiated human macrophages using HIV-1 based lentiviral vectors. BMC Biotechnol. 11, 13 (2011).
22. Manning, J. S., Hackett, A. J. & Darby, N. B. Effect of polycations on sensitivity of BALD-3T3 cells to murine leukemia and sarcoma virus infectivity. Appl. Microbiol. 22, 1162-1163 (1971).
23. Cornetta, K. & Anderson, W. F. Protamine sulfate as an effective alternative to polybrene in retroviral-mediated genetransfer: implications for human gene therapy. J. Virol. Methods 23, 187-194 (1989).
24. Kaplan, M. M., Wiktor, T. J., Maes, R. F., Campbell, J. B. & Koprowski, H. Effect of polyions on the infectivity of rabies virus in tissue culture: construction of a single-cycle growth curve. J. Virol. 1, 145-151 (1967).
25. Hanenberg, H. et al. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nature Med. 2, 876-882 (1996).
26. Hanenberg, H. et al. Optimization of fibronectin-assisted retroviral gene transfer into human CD34\+ hematopoietic cells. Hum. Gene Ther. 8, 2193-2206 (1997).
27. Pollok, K. E. et al. High efficiency gene transfer into normal and adenosine deaminase deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J. Virol. 72, 4882-4892 (1998).
28. Millington, M., Arndt, A., Boyd, M., Applegate, T. & Shen, S. Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells. PLoS ONE 4, e6461 (2009).
29. Kustikova, O. S. et al. Retroviral vector insertion sites associated with dominant hematopoietic clones mark 'stemness' pathways. Blood 109, 1897-1907 (2007).
30. Knowles, T. P. et al. Role of intermolecular forces in defining material properties of protein nanofibrils. Science 318, 1900-1903 (2007).